
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
0 competitors in Immunoglobulin A Nephropathy (IgAN)
View Full LandscapeTarget Indication
Immunoglobulin A Nephropathy (IgAN)
Clinical Trial
NCT07146906Last updated: 5/21/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.
Non-alcoholic Fatty Liver Disease (NAFLD)
Heart Transplantation
Influenza
Diabetic Retinopathy
Hypertension